Business, Economics, Education, Entrepreneurs,
Environment, Science and Technology
|
|
|
|
____________________
Health Care
Evidence of Reverse Brain Drain Mounting: CAMH appoints new VP of Research
TORONTO - The Centre for Addiction and Mental Health (CAMH) is pleased and honoured to welcome Bruce Pollock MD, PhD, FRCP to the hospital's senior leadership team as the Vice President of Research. Dr. Pollock is also Professor and Head, Division of Geriatric Psychiatry at the University of Toronto as well as the Sandra A. Rotman Chair in Neuropsychiatry, Rotman Research Institute, Baycrest.
A researcher and clinician, Dr. Pollock is internationally recognized for
his work in geriatric psychopharmacology (studying actions, effects, and
development of medications that impact brain function). "CAMH is extremely
fortunate to have one of the world's leading clinical psychopharmacologists at
the helm of our research program," said President and CEO Dr. Paul Garfinkel.
"Dr. Pollock's pioneering research, clinical and administrative skills are the
catalyst we need to take CAMH science to the next level of excellence."
The keen interest and dedication to growing the Research Program is
mutual. "I am energized by the remarkable depth and breadth of CAMH's
scientific work and scientific achievements, and the program's commitment to
research excellence that translates into improved care," said Dr. Pollock. "My
goal is to nurture this compassionate approach to science and foster synergies
among the diversity of disciplines and paradigms, so that CAMH science stands
as a beacon of hope to patients and families in our community, throughout the
province and around the world."
As a scientist, Dr. Pollock is part of CAMH's Geriatric Mental Health
program - a rapidly emerging leader in this area of study. This dynamic
program completed the first known positron emission tomography (PET) study of
elderly patients with schizophrenia, and was awarded its first significant
external grant from the National Institutes of Health. As co-principal
investigator, Dr. Pollock will join forces with scientists from three US-based
universities and CAMH colleagues, to continue exploring novel treatments for
the behavioral disturbances of dementia.
In this new role, Dr. Pollock is also actively working to bring together
the Rotman Research Institute's world-class strengths in cognitive
neuroscience and functional imaging with CAMH's substantial capacities in
genetics and PET. As he explains, linking investigators and resources from
these two scientific powerhouses will enhance the scientific activity in both
research programs for the benefit of our community.
Part of the 'reverse brain drain', CAMH attracted Dr. Pollock back to
Toronto and CAMH from Pittsburgh in 2006, where he was Chief of the Academic
Division of Geriatrics and Neuropsychiatry and Professor of Psychiatry,
Pharmacology and Pharmaceutical Sciences at the University of Pittsburgh
School of Medicine, as well as Director of the Department of Psychiatry's
Clinical Therapeutics Research program. He is the first Canadian President of
the 2,000-member American Association for Geriatric Psychiatry (AAGP).
Dr. Pollock earned his medical degree from the Faculty of Medicine of the
University of Toronto and his PhD in pharmacology from the University Of
Pittsburgh School Of Medicine. He completed his internship at the Toronto
Hospital and was Chief Resident at the former Clarke Institute in Toronto, now
part of CAMH. Dr. Pollock has held several prestigious research career awards
such as the Centennial Fellowship of the Canadian Medical Research Council, an
Academic Award in Geriatric Mental Health, and an Independent Scientist Award
from the United States' National Institute of Mental Health.
The Centre for Addiction and Mental Health (CAMH) is Canada's largest
mental health and addiction teaching hospital, as well as one of the world's
leading research centres in the area of addiction and mental health. CAMH is
fully affiliated with the University of Toronto, and is a Pan American Health
Organization/World Health Organization Collaborating Centre.
CAMH combines clinical care, research, education, policy development and
health promotion to transform the lives of people affected by mental health
and addiction issues.
|
|
|
| © Copyright 2008/Exchange Morning Post/Exchange Business Communications Inc. |
